Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Alvarez

Showing results (221-230 of 236) with videos related to

Pageof 24
Sort By:
Cancer Cytopathology|June 11, 2020
Benefit of double-reading cytology smears as a triage strategy among high-risk human papillomavirus-positive women in MexicoPaula Ramírez-Palacios, Aiyu Chen, Yvonne N Flores, et al.
Genes|October 24, 2017
Functional Characterization of Rare RAB12 Variants and Their Role in Musician's and Other DystoniasEva Hebert, Friederike Borngräber, Alexander Schmidt, et al.
Annals of the Rheumatic Diseases|May 23, 2013
Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER studyGerd Horneff, Ruben Burgos-Vargas, Tamas Constantin, et al.
Nature Communications|August 30, 2024
RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockadeMarie-Julie Nokin, Alessia Mira, Enrico Patrucco, et al.
Clinical Immunology (Orlando, Fla.)|January 22, 2025
The immune response to SARS-CoV-2 in COVID-19 as a recall response susceptible to immune imprinting: A prospective cohort studyDaniel Alvarez-Sierra, Mónica Martínez-Gallo, Adrián Sánchez-Montalvá, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 17, 2026
Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose AdalimumabAnika M Valk, Jolinde van Strien, Ninotska Derksen, et al.
BMJ Open|March 7, 2023
Targeting patient recovery priorities in degenerative cervical myelopathy: design and rationale for the RECEDE-Myelopathy trial-study protocolBenjamin Davies, Oliver D Mowforth, Stefan Yordanov, et al.
Trends in Psychiatry and Psychotherapy|April 24, 2025
Independent and Joint Associations of Physical Fitness and Mental Health Symptoms in University Students: A Cross-sectional AnalysisMaria E A Guimarães, Debora Tornquist, Eduarda Bitencourt Dos Santos, et al.
Chemmedchem|January 12, 2013
Fueling open-source drug discovery: 177 small-molecule leads against tuberculosisLluís Ballell, Robert H Bates, Rob J Young, et al.
Plos One|December 8, 2015
Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discoveryMaría Jose Rebollo-Lopez, Joël Lelièvre, Daniel Alvarez-Gomez, et al.
Pageof 24

Showing results (221-230 of 236) with videos related to

Sort By:
Pageof 24
Cancer Cytopathology|June 11, 2020
Benefit of double-reading cytology smears as a triage strategy among high-risk human papillomavirus-positive women in MexicoPaula Ramírez-Palacios, Aiyu Chen, Yvonne N Flores, et al.
Genes|October 24, 2017
Functional Characterization of Rare RAB12 Variants and Their Role in Musician's and Other DystoniasEva Hebert, Friederike Borngräber, Alexander Schmidt, et al.
Annals of the Rheumatic Diseases|May 23, 2013
Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER studyGerd Horneff, Ruben Burgos-Vargas, Tamas Constantin, et al.
Nature Communications|August 30, 2024
RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockadeMarie-Julie Nokin, Alessia Mira, Enrico Patrucco, et al.
Clinical Immunology (Orlando, Fla.)|January 22, 2025
The immune response to SARS-CoV-2 in COVID-19 as a recall response susceptible to immune imprinting: A prospective cohort studyDaniel Alvarez-Sierra, Mónica Martínez-Gallo, Adrián Sánchez-Montalvá, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 17, 2026
Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose AdalimumabAnika M Valk, Jolinde van Strien, Ninotska Derksen, et al.
BMJ Open|March 7, 2023
Targeting patient recovery priorities in degenerative cervical myelopathy: design and rationale for the RECEDE-Myelopathy trial-study protocolBenjamin Davies, Oliver D Mowforth, Stefan Yordanov, et al.
Trends in Psychiatry and Psychotherapy|April 24, 2025
Independent and Joint Associations of Physical Fitness and Mental Health Symptoms in University Students: A Cross-sectional AnalysisMaria E A Guimarães, Debora Tornquist, Eduarda Bitencourt Dos Santos, et al.
Chemmedchem|January 12, 2013
Fueling open-source drug discovery: 177 small-molecule leads against tuberculosisLluís Ballell, Robert H Bates, Rob J Young, et al.
Plos One|December 8, 2015
Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discoveryMaría Jose Rebollo-Lopez, Joël Lelièvre, Daniel Alvarez-Gomez, et al.
Pageof 24